David Zemmour
Assistant Professor, Pathology University of Chicago
Dr. Zemmour is a physician-scientist passionate about T cell biology and immune regulation. After earning an M.D. from Sorbonne University in Paris, he completed a Ph.D. in Immunology at Harvard, where he discovered FLICR, a long non-coding RNA regulating FOXP3 and Treg function. He trained in Clinical Pathology and Hematopathology at Brigham and Women’s Hospital, studying IPEX syndrome and defining the molecular impact of FOXP3 mutations. Now in Chicago, his lab explores T cell communication, Treg biology, and immune homeostasis to inform new therapies for autoimmunity and tissue repair.
Seminars
Tuesday 24th March 2026
NEW DATA: Exploring Treg Functionality & Immune Cell Interactions Induced by Treg Therapies to Enhance Therapeutic Efficacy
9:00 am
- Unearthing the mechanisms that induce Treg proliferation and enhance function
- Investigating the role of chemokines in immune regulation to understand how Tregs impact T effector and surrounding immune cells
- Discussing if Tregs alone have enough functionality and therapeutic impact to combat disease
